当前位置:首页 - 行情中心 - 泽璟制药-U(688266) - 财务分析

泽璟制药-U

(688266)

  

流通市值:174.18亿  总市值:174.18亿
流通股本:2.65亿   总股本:2.65亿

泽璟制药-U(688266)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-1.10亿元,每股收益-0.37元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益130280.60万元,未分配利润-207681.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产296714.79万元,负债166434.19万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入384,117,191.62240,696,731.58108,244,408.58386,438,784.02
营业总成本509,620,185.43330,471,226.37158,939,244.62778,740,484.69
营业利润-112,548,101.52-79,435,959.33-45,624,274.29-297,782,398.33
利润总额-112,602,724.53-79,493,376.06-45,623,831.81-299,084,511.68
净利润-109,646,565.01-77,527,664.35-44,630,785.9-295,134,953.99
其他综合收益26,035,078.95338,774.7104,914.23-2,670,887.43
综合收益总额-83,611,486.06-77,188,889.65-44,525,871.67-297,805,841.42
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,565,243,592.542,705,741,942.972,722,994,152.52,520,336,094.4
非流动资产合计401,904,317.46393,921,082.11381,753,800.44366,870,730.91
资产总计2,967,147,9103,099,663,025.083,104,747,952.942,887,206,825.31
流动负债合计1,313,676,788.181,169,133,070.041,208,189,825.591,135,181,236.87
非流动负债合计350,665,123.57362,163,991.46295,846,130.38107,188,540.07
负债合计1,664,341,911.751,531,297,061.51,504,035,955.971,242,369,776.94
归属于母公司股东权益合计1,303,387,496.251,567,044,488.521,593,693,581.821,632,852,717.68
股东权益合计1,302,805,998.251,568,365,963.581,600,711,996.971,644,837,048.37
负债和股东权益合计2,967,147,9103,099,663,025.083,104,747,952.942,887,206,825.31
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计702,864,034.36540,162,054.19310,024,749.02611,870,449.9
经营活动现金流出小计636,216,963.79427,608,991.08221,000,881.05844,621,099.47
经营活动产生的现金流量净额66,647,070.57112,553,063.1189,023,867.97-232,750,649.57
投资活动现金流入小计1,016,865,822.15799,264,489.27117,324,826.941,262,440,127.61
投资活动现金流出小计1,008,410,550.44763,676,661.49433,226,291.731,197,601,229.98
投资活动产生的现金流量净额8,455,271.7135,587,827.78-315,901,464.7964,838,897.63
筹资活动现金流入小计798,000,000528,000,000349,000,0002,176,172,835.72
筹资活动现金流出小计876,125,567.19483,635,207.12254,387,860.3666,807,032.68
筹资活动产生的现金流量净额-78,125,567.1944,364,792.8894,612,139.71,509,365,803.04
汇率变动对现金及现金等价物的影响-536,724.6737,025.9210,798.48216,718.78
现金及现金等价物净增加额-3,559,949.58192,542,709.69-132,254,658.641,341,670,769.88
期末现金及现金等价物余额2,074,217,241.92,270,319,901.171,945,522,532.842,077,777,191.48
最新报告期:2024-11-04
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国泰君安丁丹,甘坛焕-0.630.301.492024-11-04
中信证券陈竹-0.58-0.011.092024-10-30
TOP↑